Safety-Related Labeling Changes
Contraindicated in Patients with decompensated cirrhosis (e.g., Child-Pugh Class B or C) or a prior decompensation. Hepatic adverse events
Trade Name
Ocaliva
Updated Section
4.4 special warnings and precautions for use 4.8. Undesirable effects
Month
Oct, 2025